Plotting a route out of the pandemic and towards world-leading cancer services.
The UK report provides an insight into the impact of treatment and care for people living with lymphoma.
Read the UK report
New report finds two thirds of blood cancer patients are concerned about accessing the most effective treatment.
Charities urge Governments to minimise the impact of COVID-19 for people living with cancer.
If you have a health concern please don’t put it off - contact your GP.
Lymphoma Action ensure that the patient voice is heard at HTAs, resulting in better access to the latest treatments.
September is Blood Cancer Awareness Month, and an opportunity to reflect on the events of the past few months. In a message to our supporters, Professor John Radford, President of Lymphoma Action, talks about the impact of the COVID-19 pandemic on people affected by lymphoma, and what healthcare services could look like for people living with a lymphoma diagnosis in the future.
As September is Blood Cancer Awareness Month, we explain what makes lymphoma a type of blood cancer.
Following on from the launch of our free Distance Aware badge as part of an initiative with NHS Wales, the Department of Health and Social Care and the UK Government have now confirmed their endorsement of the #DistanceAware campaign.
We have united with 24 other cancer charities to develop a 12-point plan for restoring cancer services.
What makes lymphoma a type of blood cancer?
Today marks the 20th anniversary of World Cancer Day – a global movement to raise awareness and understanding of cancer and to ensure that cancer treatment and care is equal for all.
We want to hear from you! Please share your experiences in this new survey.
Today - in collaboration with 28 charities - we’ve launched a manifesto for people living with cancer. We’re calling on the next Government to improve prevention, diagnosis, treatment and care.
Collaborating to make blood cancer data visible.
Raising awareness of blood cancers and blood stem cell donation
Stephen Scowcroft is the new chair of the Alliance of twelve charities representing people living with blood cancer.
Head of Business Development, Stephen Scowcroft, represented Lymphoma Action in Brussels.
Have your say on brentuximab vedotin for cutaneous T-cell lymphoma
The NHS Long Term Plan has been published and whilst lymphoma is not specifically mentioned, we're glad to see the more personalised, co-ordinated approach to cancer care. We hope the government supports the commitments with the resources and staffing needed.
Have your say on bendamustine with rituximab for relapsed low-grade non-Hodgkin lymphoma.
Stephen Scowcroft, our Business Development Manager, reports back from the European Society of Medical Oncology (ESMO) Congress 2018 #ESMO18.
Our response to the recent consultation on the NHS long term plan.
Under the banner 'Right To Be Forgotten' Youth Cancer Europe call for EU-wide legislation to end financial discrimination for cancer survivors.
We're supporting the MBCV campaign alongside eight blood cancer patient groups.
Stephen Scowcroft, our Business Development Manager summarises the Lymphoma Coalition Global Summit 2018 held in Prague in July 2018
Health Information Week is an annual campaign to promote the quality health resources available.
Read our response to The Hidden Cancer: The need to improve blood cancer care.